Methods for treating resistant tumors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/38 (2006.01) A61K 31/216 (2006.01) A61K 31/34 (2006.01) A61K 31/343 (2006.01) A61K 31/381 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/445 (2006.01) A61K 31/4525 (2006.01) A61K 31/4535 (2006.01) A61K 31/55 (2006.01) A61K 31/70 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2202661

The present invention provides methods for reversing multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituded indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene. This invention also provides methods for treating neoplasms in a mammal which comprises administering to a mammal in need of this treatment a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene in combination with an oncolytic agent.

La présente invention se rapporte à des procédés pour faire rétrocéder la résistance multiple aux anticancéreux dans un néoplasme réfractaire, en traitant un mammifère, dont l'état requiert un tel traitement, avec un indole, benzofurane, benzothiophène, naphtalène, ou dihydronaphtalène substitué. L'invention concerne également des procédés pour traiter des néoplasmes chez un mammifère, consistant à administrer à un mammifère, dont l'état requiert un tel traitement, un indole, benzofurane, benzothiophène, naphtalène, ou dihydronaphtalène substitué en association avec un agent oncolytique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for treating resistant tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating resistant tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating resistant tumors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1577624

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.